Saul Priceman, Associate Professor at Keck School of Medicine of USC, and Founding Director of KSOM/NCCC Center for Cancer Cellular Immunotherapy Research, shared a post on LinkedIn:
“Excited to share our new solid tumor CAR T cell review published in Med by Cell Press. This is a comprehensive review on the current state of the field including clinical trial updates and the breadth of ongoing preclinical work with future perspectives.
Congrats to Reginaldo Rosa, Venna Jiangyue Liu, Cathy Lu, Mohamed Abou-el-Enein and John P. Murad. Honored to continue contributing to this field and to the promising future of solid tumor cellular therapies.”
Title: Current state of CAR-T cell therapies for solid tumors
Authors: Reginaldo Rosa, Jiangyue Liu, Cathy Lu, Mohamed Abou-El-Enein, John P. Murad, Saul J. Priceman
Read the Full Article.
Other articles featuring Saul Priceman.